• uconn
  • uconn health
Page content relevant to:

Innovation Funding Opportunities

Below you will find a list of funding opportunities for research faculty and students in the areas of Agricultural Sciences, Animal Sciences, Life Sciences, Physical Sciences and opportunities for startups.  If you would like to have an opportunity added to the below list please contact: Taylor Renaud

COVID-19 Research Opportunities

Agricultural Sciences

Program

Deadline

Description

Corteva is Interested in Partnerships and Collaborations Rolling Admissions See website for proposal areas of interest.
Bayer Partnering Opportunities Admission Dates Vary Bayer’s vision of #HealthForAll, #HungerForNone drives our need to strengthen innovation capabilities in all areas of agriculture. We know we can’t accomplish this alone, so we’re always interested to hear about novel, early-stage scientific innovations that can contribute to feeding the world without starving the planet. You have our commitment to take a look, match with our R&D priorities and provide you timely feedback.
BASF Admission Dates Vary Join us in our efforts to innovate for a sustainable future: we welcome you to bring in your expertise to help with our ongoing challenges. Beyond that, we regularly offer opportunities for external collaboration in temporary campaigns. Additionally, in our open collaborations, you may find a perfect match with your profile. Take initiative and get in touch with us.
Rolling Admissions Nitrogen is a key requirement for crop growth and building healthy soil supports sustainable crop production. The aim of this project is to identify and validate microbiome health technologies which reduce the reliance on synthetic agrochemicals applied to and/or improve soil health in potato, oat, citrus and corn crops, whilst maintaining yield and quality.
NATURAL SYSTEMS FOR REDUCTION IN PESTICIDES, FUNGICIDES, AND FERTILIZERS ON KEY CROPS Rolling Admissions Mondelēz International seeks natural, safe means for increasing growth of key crops such as wheat and cocoa and/or to fight common insect pests and diseases such as fusarium head blight in wheat and Vascular Streak Dieback black pod, pink disease and witches´ broom in cocoa.

Animal Sciences

Program

Deadline

Description

Call for opportunities – technologies or drugs in the animal therapeutic area Rolling Admissions See website for proposal areas of interest.

Life Science

Program

Deadline

Description

New Therapeutic Strategies Targeting Myeloid Malignancies October 25th, 2021 Our client is seeking to identify therapeutics and associated research focused on resolution of Myeloid Malignancies.
Closing Knowledge Gaps in Moderate-to-Severe Atopic Dermatitis for Allergists October 28th, 2021 The intent of this RFP is for the American College of Allergy, Asthma, & Immunology and Pfizer to support projects that offer a comprehensive educational intervention to improve the ability of allergy practitioners to manage moderate to severe atopic dermatitis specifically in their ability to:

  • Diagnose moderate-to-severe atopic dermatitis in different skin types and specifically skin of color.
  • Make informed selection of therapies available now and in the pipeline, while managing the safety of and duration of treatment with systemic agents.
  • Provide personalized care appropriate for differences in age and ethnicity.
  • Educate patients on their role in successful disease management.

Assess the guidelines around vaccination requirements with immunosuppressive therapies.

Seeking Monogenic Targets for RNA Interference-Based Therapy November 1st, 2021 Benitec Biopharma is an American biotechnology company looking for monogenic targets that can be downregulated by RNAi-based therapy.
Call for opportunities in the field of Women health and auto-immune diseases November 10th, 2021 Please see website for details
Seeking Genetically-Based Early Discovery Research in Nephrology November 15th, 2021 A world leader in rare disease therapies, BioMarin Pharmaceutical are looking for early discovery research that involve targets with strong genetic evidence in the area of kidney disease.
Emerging Therapies for Atopic Dermatitis and Alopecia Areata for Advanced Practice Providers November 16th, 2021 Through this RFP, it is our intent to support educational projects that focus on addressing knowledge and practice gaps specific to the recognition, diagnosis, treatment, and overall care management of Atopic Dermatitis (AD) and Alopecia Areata (AA). Projects that will be considered for Pfizer support should focus on increasing the knowledge and understanding of:

  • the pathophysiology of AA and AD with specific focus on immunologic pathways
  • the epidemiology of the disease(s), including an understanding of the risk factors for the development of the disease(s), comorbidities, and safety events relevant to systemic therapies
  • understanding the clinical manifestation of AD/AA, including a holistic review of the burden of disease (e.g.: psychosocial burden and associated autoimmune and atopic disorders)
  • new advances in the treatment pathways of AA and AD
  • mechanism of action of treatments in AA and AD

the benefit/risk profile of systemic treatments for AA and AD treatments (e.g.: JAK inhibitors)

Next Generation Gene Regulation Technology Applicable for AAV Based Gene Therapy November 22nd, 2021 Ultragenyx is interested in research focused on innovative gene regulation technology for Adeno-associated virus (AAV) based gene therapy.
Research Programme for Rare and Ultra-Rare Diseases November 22nd, 2021 Ultragenyx is seeking research focused on rare and ultra rare diseases.
Kidney Disease Focused Drug Discovery and Early Pre-Clinical Development November 22nd, 2021 Our client is interested in early stage drug discovery and preclinical research to identify therapeutic approaches to treat kidney diseases.
Heterologous expression of natural products in fungal hosts November 30th, 2021 We are seeking short, non-confidential proposals that describe a plan to demonstrate the transfer of and expression from large fungal biosynthetic gene clusters in a heterologous fungal (yeast or filamentous fungi) host, leading to detectable production of natural products.
Cardiac Amyloidosis Mentor mATTch Program December 2nd, 2021 The goals of the Cardiac Amyloidosis Mentor mATTch pRogram are to:

  • Support the development of emerging Cardiac Amyloid Centers to ensure health equity and address health care disparities across the United States for patients with ATTR-CM
  • Enable Mentor to guide Mentee towards achieving his/her developmental objectives ultimately ensuring appropriate diagnosis, treatment, management, and comprehensive care of patients with ATTR-CM
  • Provide emerging centers a Community of Practice to share ideas, best practices and ask for feedback
CSL Research Acceleration Initiative  December 10th, 2021 CSL’s Research Acceleration Initiative aims to fasttrack discovery of innovative biotherapies through partnerships between CSL and global research organizations. These partnerships provide funding and access to industry experts for scientists working on novel biotherapeutic strategies in CSL’s therapeutic areas. Expressions of interest are sought from Business Development / Commercialization representatives across global research organizations that wish to participate in the 2022 CSL Research Acceleration Initiative
Multidisciplinary Gene Therapy Education – Recombinant Adeno-Associated Virus (rAAV) December 21st, 2021 Through this RFP we seek to support educational initiatives that focus on one or both of the following:

  • Improving the medical and scientific understanding of recombinant adeno-associated virus (rAAV) gene therapy to help prepare multidisciplinary teams for the integration of rAAV gene therapy into the treatment armamentarium of eligible patients with a Rare Disease.

Advancing the preparedness of gene therapy centers with institutional and/or multidisciplinary team training to execute clinical and operational best practices (e.g., SOPs and workflows) to optimize the quality of care for patients who are eligible for available recombinant adeno-associated virus (rAAV) gene therapies.

Request for Proposals (RFP)
2021/2022 Global Cachexia ASPIRE
January 7, 2022 The intent of this RFP is to support research projects in the following areas of interest:

  • Evidence generation in Understanding Cachexia/Unintentional Weight Loss in Cancer or Heart Failure
  • Role of GDF-15/GFRAL Pathway in Disease
  • GDF-15/GFRAL Biology

Natural History (longitudinal) studies specifically related to cachexia/weight loss and/or heart failure

AstraZeneca open innovations Rolling Admissions Multiple opportunities.  Please refer to website for details.
Improving Detection of AL Amyloidosis (IDEA) QuickFire Challenge Rolling Admissions We’re interested in products, technologies, or methodologies, which may be translational or clinical in nature.

We encourage applications from visionaries – including entrepreneurs/startups, hematologists, cardiologists, radiologists, and nephrologists familiar with AL amyloidosis, basic science researchers, and patient advocates – working on potentially ground-breaking ideas or technologies in AL amyloidosis that aim to:

  • Increase awareness of disease symptoms and improve recognition of disease among HCPs
  • Improve identification/testing of patients
  • Develop blood test/biomarkers for AL amyloidosis
  • Develop nuclear medicine imaging with amyloid-specific tracers
  • Create AI-based screening tools
  • Facilitate EMR-based research
  • Produce Epidemiology studies
Request for Proposals (RFP)
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Rolling Admissions Projects that will be considered for Pfizer support will focus on
improving the care of patients by:
• Educating [HCPs] to increase awareness and enable appropriate
patient identification by closing knowledge gaps in disease
epidemiology, pathophysiology, diagnosis, and emerging
treatment paradigms.
• Addressing barriers to appropriate diagnosis and strategies that
reduce burdens for patients and providers along the pathway to
appropriate diagnosis
• Exploring strategies that empower patients to play an active role
in understanding TTR amyloidosis and decision making regarding
available diagnostic and treatment options
• Increasing awareness of the changing epidemiology of TTR
amyloidosis with a focus on the prevalence of hereditary ATTR
and wild-type ATTR subtypes as the science continues to evolve
• Increasing awareness of at risk and undiagnosed populations with
TTR amyloidosis with a focus on improving strategies that
facilitate the appropriate diagnosis of patients early in the disease
course before overt cardiomyopathy has ensued [e.g. populations
with electrical disturbances, valvular disease, orthopedic
Rare Treatment Accelerator (RTA) Rolling Admissions The Rare Treatment Accelerator programme connects academic groups, patient groups and early-stage biotechs with Healx to unlock the power of repurposed drugs for rare diseases. Working together, we can quickly turn your research, insights and promising repurposing assets into treatments that will benefit rare disease patients
Pfizer-Vaccines Areas of Interest Rolling Admissions Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. 
Pfizer- Inflammation and Immunology Areas of Interest Rolling Admissions Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. 
Pfizer- Rare Disease Areas of Interest Rolling Admissions Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. 
Pfizer- Internal Medicine Areas of Interest Rolling Admissions Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. 
Cyclica Academic Partnership Program

 

Rolling Admissions Ligand Design Award
Generate novel compounds with desired ADMET properties that are specific to your target(s) of interest while avoiding anti-target(s)Ligand Express Award
Screen existing compounds for mechanisms of action, ADMET predictions, or repurposing opportunities. Cyclica is committed to award at least two labs at the University of Connecticut

 

Physical Sciences

Program Deadline Description
NCET2:Corporate Needs List October 29th, 2021 We accept submissions for the Corporate Needs List on a regular basis. For startups, university tech transfer offices, accelerators, investors, and other portfolio company holders. Feedback and responses to submissions are given 3-4 weeks after each deadline.
Baxter Partnering Opportunities October 31st, 2021 See website for proposal areas of interest.
NCET2: EV Open Innovation Challenge November 8th, 2021 Hyundai wants to work with startups to rapidly scale EV charging services in North America.

The EV Open Innovation Challenge is a program powered by New Energy Nexus to source startups of commercial-ready EV charging products and services to enter into pilot or proof-of-concept projects with industry champions Kia, Hyundai Motor, Hyundai Glovis US, and Hyundai CRADLE. This program is a launchpad to rapidly scale the product offering in North America.

Halo Science-Expanded temperature ranges for adhesives Rolling Admissions The sponsor is seeking novel approaches to expand the temperature range of these commercial adhesives to temperatures below 4 C°. Potential solutions from adjacent industries are of significant interest, including novel materials, innovations in manufacturing processes and engineering solutions. Possible partnerships include contract research, providing grant monies, or other forms of investment.

Solutions of interest include:

Materials substitution, multifunctional materials, engineered products, or novel material structures
Curing agents or additives that lower the operational temperature window
Modifications to current manufacturing processes
Coatings, surface treatments, sealing agents, or other post-processing solutions would be considered but are of a lower priority than other methods

BASF Admission Dates Vary Join us in our efforts to innovate for a sustainable future: we welcome you to bring in your expertise to help with our ongoing challenges. Beyond that, we regularly offer opportunities for external collaboration in temporary campaigns. Additionally, in our open collaborations, you may find a perfect match with your profile. Take initiative and get in touch with us.
Shell N/A See website for more details.

Software

Program Deadline Description

Startup/Entrepreneurship

Program Deadline Description
Sanofi Pharma Days  October 18th and 19th, 2021 See website for details.